Search results
Trust Co. of Toledo NA OH Acquires 6,696 Shares of GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoTrust Co. of Toledo NA OH boosted its position in shares of GSK plc (NYSE:GSK – Free Report) by 37.3% in the 1st quarter, according to its most recent filing ...
PNC Financial Services Group Inc. Has $11.03 Million Position in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 5 days agoPNC Financial Services Group Inc. reduced its position in shares of GSK plc (NYSE:GSK – Free Report) by 27.5% during the 4th quarter, according to the company ...
GSK (LON:GSK) Given Underweight Rating at JPMorgan Chase & Co.
ETF DAILY NEWS· 5 days agoJPMorgan Chase & Co. reissued their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com ...
NBC Securities Inc. Has $1.43 Million Stock Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoNBC Securities Inc. trimmed its position in GSK plc (NYSE:GSK – Free Report) by 1.7% in the first quarter, according to the company in its most recent Form ...
Leo Wealth LLC Purchases New Shares in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 6 days agoLeo Wealth LLC purchased a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent filing with ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks via Yahoo Finance· 4 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer Stock And Recent News Pfizer recently said its respiratory syncytial virus vaccine, Abrysvo,...
Citi holds Buy rating on Mirum stock on positive trial updates By Investing.com
Investing.com· 6 days agoOn Monday, Citi maintained a Buy rating on Mirum Pharmaceuticals (NASDAQ:MIRM) with a steady price...
New Drug Provides Total Protection From H.I.V. in Trial of Young African Women
New York Times· 2 days agoStephanie Nolen has covered the global H.I.V. pandemic for more than 25 years. Researchers and...